CMC’s facilities offer multiple cGMP manufacturing lines for mammalian cells and microbial fermentation. Capacity ranges from pilot scale up to clinical manufacturing volumes of 3000L (batch) and 2000L/day (perfusion). The design of both facilities allows for capacity and technological flexibility, while ensuring compliance with the strict pharmaceutical regulations required for cGMP.
When you choose to manufacture at either of the CMC facilities, you benefit from over 15 years of biologics process development, transfer, and cGMP manufacturing expertise. We provide experienced people dedicated to the successful completion of your project and committed to meeting your goals.